SCHEMBL7110475

SCHEMBL7110475

O=[N+]([O-])c1cccc(OCc2ccccc2)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.53
ADRA1D P25100 1/20 0.53
ADRA1A P35348 1/20 0.53
ADRA1B P35368 1/20 0.53
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SGMS2 Q8NHU3 1/20 0.50
RECQL P46063 1/20 0.50
PTGES O14684 2/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
POLB P06746 2/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
ATM Q13315 1/20 0.48
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL573839 0.88 CTSV (0.49) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL30015078 0.85 NPC1 (0.68) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL2305236 0.85 NPC1 (0.68) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL20876320 0.85 NPC1 (0.54) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL9528862 0.83 HTR1A (0.54) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL2477351 0.82 CTSV (0.50) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL573614 0.82 MAPT (0.53) HTR1AADRA1DADRA1AADRA1BPTGES
SCHEMBL23294854 0.82 HTR1A (0.53) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL1141905 0.82 TDP1 (0.65) HTR1AADRA1DADRA1AADRA1BNPC1
SCHEMBL1937817 0.82 HTR1A (0.53) HTR1AADRA1DADRA1AADRA1BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057771-B Macrocyclic compounds, their preparation and use 北京鞍石生物科技有限责任公司 2023-10-03 CN disclosed
CN-111511750-B Macrocyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2023-06-13 CN disclosed
WO-2022117051-A1 MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京鞍石生物科技有限责任公司 2022-06-09 WO disclosed
WO-2022117051-A1 MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京鞍石生物科技有限责任公司 2022-06-09 WO disclosed
CN-114057771-A Macrocyclic compound and preparation method and application thereof 北京鞍石生物科技有限责任公司 2022-02-18 CN disclosed
EP-3204360-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF Genentech, Inc. (US) 2017-08-16 EP disclosed
WO-2016055028-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-04-14 WO disclosed
EP-1289952-A1 INDOLE DERIVATIVES WITH VASCULAR DAMAGING ACTIVITY AstraZeneca AB (SE) 2003-03-12 EP disclosed
WO-2001092224-A1 INDOLE DERIVATIVES WITH VASCULAR DAMAGING ACTIVITY ASTRAZENECA AB (SE) 2001-12-06 WO disclosed